Get started
Author

Victor Tomacinschii

Observed names: Tomacinschii Victor, Tomacinschii, V., Tomacinschii, Victor, V. Tomacinschii, Victor TOMACINSCHII, Victor Tomacinschi
ORCID: 0000-0002-5907-1714
Observed ORCID: 0000-0002-5907-1714
OpenAlex ID: A5073334371
The implication of next-generation sequencing in the diagnosis and clinical management of non-Hodgkin lymphomas
2023 · Victor Tomacinschii, Adrian Mosquera Orgueira, et al. · Frontiers in Oncology · 6
PDF
Clinical application of HALP score in the determination of nodal non-Hodgkin lymphoma prognosis
2023 · Victor TOMACINSCHII, Sanda BURUIANA, et al. · Documenta Haematologica - Revista Romana de Hematologie · 3
PDF
Therapy-Induced Cellular Senescence in Non-Hodgkin Lymphomas, with Emphasis on Aggressive B-Cell Subtypes: Molecular Mechanisms and Emerging Drug Targets
2026 · Victor Tomacinschii, Andreea Casian, et al. · Current Cancer Drug Targets · 2
The crosstalk between epigenetics and metabolism in the malignant cell
2026 · Adrian Bogdan Tigu, Andrei Ivancuta, et al. · Discover Oncology · 2
Hepatitis B and C infections among lymphoma patients: a national study in the Republic of Moldova
2022 · Ivan Negara, Sanda Buruiana, et al. · The Journal of Infection in Developing Countries · 2
PDF
Impact of targeted treatment in non-Hodgkin’s lymphoma with primary lymph node involvement
2021 · Victor Tomacinschii, Maria Robu, et al. · The Moldovan Medical Journal · 2
PDF
ABCL-311: The Burden of Non-Hodgkin Lymphoma Developed in an Ataxia Telangiectasia Child
2020 · Cristina Tomacinschii, Rodica Selevestru, et al. · Clinical Lymphoma Myeloma & Leukemia · 2
ABCL-365: Non-Hodgkin Lymphoma Developed in the Clinical Course of a Child with Wiskott-Aldrich Syndrome
2021 · Cristina Tomacinschii, Svetlana Sciuca, et al. · Clinical Lymphoma Myeloma & Leukemia · 1
ABCL-306: Clinical Application of HALP Score in the Determination of Nodal Diffuse Large B-Cell Lymphoma Prognosis
2021 · Victor Tomacinschii, Sanda Buruiana, et al. · Clinical Lymphoma Myeloma & Leukemia · 1
Stevens–Johnson syndrome secondary to rituximab administration in a chronic lymphocytic leukemia patient
2020 · V. Tomacinschii, M. Robu, et al. · Hematology Transfusion and Cell Therapy · 1
PDF
"Assessing the quality of life in patients with non-Hodgkin’s lymphoma is a burden or an advantage?"
2020 · ", Sanda BURUIANA, et al. · Archives of the Balkan Medical Union · 1
IBCL-309: The Frequency of Anticardiolipin Antibodies in Patients with Non-Hodgkin Lymphoma
2020 · Sanda Buruiana, Minodora Mazur, et al. · Clinical Lymphoma Myeloma & Leukemia · 1
IBCL-380: Clinical Features of Non-Hodgkin Lymphomas with Primary Involvement of Peripheral Lymph Nodes in an Elderly Population
2020 · Victor Tomacinschii, Maria Robu, et al. · Clinical Lymphoma Myeloma & Leukemia · 1
Unstable Hemoglobin Disease: Systematic Literature Review Dataset and Standardised Data Extraction Template
2026 · Chatzimatthaiou, Sotiroula, Perolla, Adela, et al. · Zenodo (CERN European Organization for Nuclear Research)
Real-World Outcomes and Morphological Patterns of Aggressive Non-Hodgkin Lymphoma in Moldova: A Five-Year Retrospective Cohort Study
2026 · Artur ANTOSEL, Cristina DUDNIC, et al. · Documenta Haematologica - Revista Romana de Hematologie
PDF
Integrating Flow Cytometry in the Diagnostic Work of HIV ‐Associated Hodgkin's Lymphomas
2026 · Maria Santa, Diana Cenariu, et al. · Journal of Cellular and Molecular Medicine
Prognostic impact of MYC and BCL2 co-expression in diffuse large B-cell lymphoma treated with R-CHOP: a systematic review and meta-analysis
2026 · Artur Antosel, Zinaida Ceban, et al. · Oncology in Clinical Practice
PDF
ABCL-1068: Combined Impact of Primary Lymph Node Localization and HALP Score on Prognosis in Non-Hodgkin Lymphoma
2025 · Victor Tomacinschii, Maria Robu, et al. · Clinical Lymphoma Myeloma & Leukemia
POSTER: ABCL-299 Thromboinflammatory Biomarkers in non-Hodgkin Lymphoma
2025 · Sanda Buruiana, Maria Robu, et al. · Clinical Lymphoma Myeloma & Leukemia
ABCL-299: Thromboinflammatory Biomarkers in Non-Hodgkin Lymphoma
2025 · Sanda Buruiana, Maria Robu, et al. · Clinical Lymphoma Myeloma & Leukemia
Antiphospholipid Antibodies in Non-Hodgkin's Lymphoma
2025 · Sanda BURUIANA, Maria ROBU, et al. · Documenta Haematologica - Revista Romana de Hematologie
PDF
Scrutinizing prognostic scores’ effectiveness in non-Hodgkin’s lymphomas with primary lymph node involvement
2024 · Victor Tomacinschii · Moldovan Journal of Health Sciences
PDF
POSTER: ABCL-468 Analyzing the Significance of Prognostic Scores Incorporating Biological and Nutritional Indices on the Overall Survival of Non-Hodgkin Lymphoma Patients With Primary Lymph Node Involvement
2023 · Victor Tomacinschii, Sanda Buruiana, et al. · Clinical Lymphoma Myeloma & Leukemia
ABCL-468 Analyzing the Significance of Prognostic Scores Incorporating Biological and Nutritional Indices on the Overall Survival of Non-Hodgkin Lymphoma Patients With Primary Lymph Node Involvement
2023 · Victor Tomacinschii, Sanda Buruiana, et al. · Clinical Lymphoma Myeloma & Leukemia
Pb2364: Demographics, Pattern of Care, and Outcomes of Primary Nodal Peripheral T-cell Lymphomas. Data From the Moldovan Hematological Center.
2023 · Victor Tomacinschii, Maria Robu, et al. · HemaSphere
Works count: 68
Citation count: 25
H-index: 2
I10-index:
Year
Topic
Type